Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

Presentation

Poster: Single-cell characterization of ST-506, a BBB-penetrant epigenetic repressor of prion protein expression, in the nonhuman primate brain

Download PDF